Studies

Clinical Studies

From Cleveland Clinic & Sydney University

University of Sydney

Blood Glucose and Blood Insulin Study | Unicity Balance Fiber Matrix

The University of Sydney is a public research university located in Sydney, Australia. Founded in 1850 as Australia’s first university, it is regarded as one of the world’s leading universities. It is also home to the International Glycemic Index (GI) Database main ained by the Human Nutrit on Unit, and the Sydney University Glycemic Index Research Service (SUGiRS). The Sydney University Glycemic Index Research Service (SUGiRS) has an established commercial GI testing laboratory, where they test foods for
their glycemic index, insulin index, satiety response, and other metabolic parameters.

University of Sydney Clinical Trial

In 2001, Unicity International partnered with the University toconduct two separate studies. The purpose of one study was to quantitatively measure on the impact of their fiber-rich nutritional supplement, Bios Life Slim (now branded as Unicity Balance in most global markets), on the glycemic index of three common foods: white breadwhite riceinstant mashed potatoes

The results indicated that Unicity Balance is effective at dampening healthy individuals’ glucose and insulin responses to starchy meals. In each case, it reduced the glycemic indices from “high” glycemic foods to “medium” glycemic foods.The second study conducted was to determine how the Balance fiber matrix would affect blood glucose and blood insulin levels following the consumption of white bread.

Results showed that one serving of Unicity Balance reduced blood glucose levels by 20% and blood insulin levels by 13%, and two servings of Unicity Balance reduced blood glucose levels by 28% and blood insulin levels by 27%.

Play Video

The Cleveland Clinic Study:

Unicity Balance (Bios Life) for Cholesterol

Statins continue to be the most commonly prescribed drug with 1 in 4 North Americans over the age of 40 taking statins. Statin use has gone up more than 80% in the last 20 years.

Because of the unwanted side effects of statins, there is a growing interest in non-pharmaceutical options to these medications. Unicity Balance has been well documented with a peer-reviewed published papers as the natural non-pharmaceutical option to statin drugs for hyperlipidemia. Hyperlipidemia means your blood has too many lipids (or fats), such as cholesterol and triglycerides. One type of hyperlipidemia, hypercholesterolemia, means you have too much non-HDL cholesterol and LDL (bad) cholesterol in your blood. This condition increases fatty deposits in arteries and the risk of blockages. Unfortunately, many commonly recommended over the counter (OTC) products “claim” to offer lowering cholesterol benefits but without the science. Unicity Balance, formally called Bios Life, was first developed by scientists at the University of Santa Barbara in 1986 while conducting research using natural fibers to manage serum cholesterol. Now more than 35 years later, Unicity Balance continues to be the most recommended natural health supplement by doctors and healthcare professionals worldwide. Unicity Balance has been extensively studied, peer-reviewed, and published in the medical journals. The clinical trials have been conducted by leading medical institutions including Cleveland Clinic, UCLA, Columbia University, Mayo Clinic and Stanford School of Medicine to name just a few. Unicity Balance has been clinically proven to help restore and maintain healthy cholesterol levels four ways without adverse side effects: Fiber helps block the re-absorption of cholesterol from the intestines Plant sterols block the absorption of cholesterol from food Policosanol reduces cholesterol production by the liver Chrysanthemum enhances enzymatic breakdown and helps remove LDL cholesterol from the body Unicity Balance has been listed in the Prescribers Desk Reference (PDR) since 2002,the go-to resource for physicians requiring information about prescription and non-prescription treatment options. Unicity Balance is referenced as the first recommended course of treatment for the safe lowering of serum cholesterol.